NeuroOne Medical Technologies (NASDAQ:NMTC) and First Choice Healthcare Solutions (OTCMKTS:FCHS) Head to Head Survey

First Choice Healthcare Solutions (OTCMKTS:FCHS) and NeuroOne Medical Technologies (NASDAQ:NMTC) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, earnings, dividends, institutional ownership, risk and profitability.

Analyst Recommendations

This is a breakdown of recent ratings for First Choice Healthcare Solutions and NeuroOne Medical Technologies, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
First Choice Healthcare Solutions	0	0	0	0	0.00
NeuroOne Medical Technologies	1	1	3	0	2.40

NeuroOne Medical Technologies has a consensus target price of $1.98, indicating a potential upside of 154.27%. Given NeuroOne Medical Technologies’ stronger consensus rating and higher possible upside, analysts clearly believe NeuroOne Medical Technologies is more favorable than First Choice Healthcare Solutions.

Insider & Institutional Ownership

16.1% of NeuroOne Medical Technologies shares are owned by institutional investors. 30.8% of First Choice Healthcare Solutions shares are owned by insiders. Comparatively, 11.8% of NeuroOne Medical Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares First Choice Healthcare Solutions and NeuroOne Medical Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
First Choice Healthcare Solutions	N/A	N/A	-165.98%
NeuroOne Medical Technologies	-78.34%	-119.92%	-78.86%

Risk and Volatility

First Choice Healthcare Solutions has a beta of 0.33, indicating that its stock price is 67% less volatile than the S&P 500. Comparatively, NeuroOne Medical Technologies has a beta of 0.74, indicating that its stock price is 26% less volatile than the S&P 500.

Earnings & Valuation

This table compares First Choice Healthcare Solutions and NeuroOne Medical Technologies”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
First Choice Healthcare Solutions	$10,000.00	12.20	-$6.96 million	($0.20)	-0.02
NeuroOne Medical Technologies	$12.10 million	3.26	-$3.61 million	($0.17)	-4.59

NeuroOne Medical Technologies has higher revenue and earnings than First Choice Healthcare Solutions. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than First Choice Healthcare Solutions, indicating that it is currently the more affordable of the two stocks.

Summary

NeuroOne Medical Technologies beats First Choice Healthcare Solutions on 9 of the 14 factors compared between the two stocks.

About First Choice Healthcare Solutions

First Choice Healthcare Solutions, Inc. provides healthcare services in the United States. It develops primary care and wellness clinics focused on providing life improvement services, such as anti-aging, weight management, hormone replacement, and pharmacy services. The company is headquartered in Melbourne, Florida.

About NeuroOne Medical Technologies

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.